Trastuzumab subcutáneo: revisión de los datos clínicos y de preferencia

Martín Martorell, Paloma; Bermejo de las Heras, Begoña; Pérez-Fidalgo, J Alejandro; Huerta Alvaro, Marisol.
Rev. senol. patol. mamar. (Ed. impr.) ; 27(3): 131-137, jul.-sept. 2014.
Artículo en Español | IBECS (España) | ID: ibc-125066

Documentos relacionados

  1. Intravenous versus subcutaneous access for palliative care patients.
  2. 7th International Immunoglobulin Conference: Immunoglobulin in clinical practice.
  3. Subcutaneous infusion of fluid in children.
  4. Comparison of arterial pressure and plasma ANG II responses to three methods of subcutaneous ANG II administration.
  5. Subcutaneous vs intravenous administration of immunoglobulin in chronic inflammatory demyelinating polyneuropathy: an Italian cost-minimization analysis.
  6. Differentiating characteristics and evaluating intravenous and subcutaneous immunoglobulin.
  7. Using the MEDiPORT humanoid robot to reduce procedural pain and distress in children with cancer: A pilot randomized controlled trial.
  8. Progress in gammaglobulin therapy for immunodeficiency: from subcutaneous to intravenous infusions and back again.
  9. The Other Opioid Crisis: Just Another Drug Shortage?
  10. Subcutaneous immunoglobulin for primary and secondary immunodeficiencies: an evidence-based review.